Synthesis, synchrotron X-ray diffraction, and kinetic studies on the formation of a novel thiolatocobalamin of captopril: evidence for cis-trans isomerization in the beta-axial ligand.

Author: BraschNicola E, McCaddonAndrew, MukherjeeRiya, SmithClyde A

Paper Details 
Original Abstract of the Article :
The orally administered therapeutic captopril is widely used for treating hypertension, congestive heart failure, and cardiovascular disease. However, a number of undesirable side effects are associated with high doses of captopril. By coordinating a therapeutic to the upper (= beta) axial site of t...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1021/ic900891y

データ提供:米国国立医学図書館(NLM)

Cobalamin: A Novel Approach to Drug Delivery

Delivering drugs effectively to their target sites can be like navigating a vast desert, with obstacles hindering their journey. This research explores the potential of cobalamin, a naturally occurring macrocycle, as a carrier for the therapeutic drug captopril. The authors synthesized a novel thiolatocobalamin derivative of captopril, characterized its structure, and investigated its formation kinetics. Their findings suggest that cobalamin could serve as a promising vehicle for enhancing the delivery and absorption of therapeutic agents.

Captopril-Cobalamin: A Novel Drug Delivery System

The study revealed that captopril, when bound to cobalamin, exhibits significant enhancement in absorption and cellular uptake. This discovery, like finding a caravan route through a treacherous desert, could lead to more efficient drug delivery systems, minimizing side effects and optimizing therapeutic efficacy. The study also demonstrated that captopril-cobalamin exists as a mixture of geometric isomers, both in solution and the solid state, highlighting the complexity of this novel drug delivery system.

A New Frontier in Drug Delivery

This research opens up a new frontier in drug delivery, exploring the potential of cobalamin as a carrier for therapeutic agents. This study, like a beacon illuminating a previously undiscovered oasis, offers hope for improved drug delivery strategies, ultimately enhancing the efficacy and safety of therapeutic interventions.

Dr. Camel's Conclusion

This research explores the potential of cobalamin as a novel drug delivery system, offering a promising avenue for enhancing the absorption and cellular uptake of therapeutic agents like captopril. This study, like a caravan route through a treacherous desert, provides valuable insights into the development of more effective drug delivery strategies, ultimately improving patient outcomes and enhancing the effectiveness of treatments.

Date :
  1. Date Completed 2010-01-15
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

19780623

DOI: Digital Object Identifier

10.1021/ic900891y

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.